TRAIL pathway components and their putative role in granulosa cell apoptosis in the human ovary

Differentiation

Volumn 77, Issue 4, 2009, Pages 369-376

  Jaaskelainen M ^a,b   Kyronlahti A ^c   Anttonen, M ^c   Nishi, Y ^d   Yanase, T ^d   Secchiero, P ^e   Zauli, G ^e   Tapanainen, J S ^a,b   Heikinheimo, M ^c,f   Vaskivuo, T E ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d KYUSHU UNIVERSITY   (Japan)

^e UNIVERSITY OF FERRARA   (Italy)

^f WASHINGTON UNIVERSITY   (United States)

Author keywords

Apoptosis; Development; Oocyte; Ovary; TRAIL

Indexed keywords

CASPASE INHIBITOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3;

APOPTOSIS; ARTICLE; CELL TYPE; CONTROLLED STUDY; FEMALE; FETUS; GRANULOSA CELL; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

APOPTOSIS; FEMALE; FETUS; GENE EXPRESSION REGULATION; GRANULOSA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; OVARY; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 61649122367     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2008.12.001     Document Type: Article

References (39)

1. Abir R., Orvieto R., Dicker D., Zukerman Z., Barnett M., and Fisch B. Preliminary studies on apoptosis in human fetal ovaries. Fertil. Steril. 78 (2002) 259-264
2. Baker T.G. A quantitative and cytological study of germ cells in human ovaries. Proc. R. Soc. London B Biol. Sci. 158 (1963) 417-433
3. Chen L., Liu X., Zhu Y., Cao Y., Sun L., and Jin B. Localization and variation of TRAIL and its receptors in human placenta during gestation. Life Sci. 74 (2004) 1479-1486
4. Clancy L., Mruk K., Archer K., Woelfel M., Mongkolsapaya J., Screaton G., Lenardo M.J., and Chan F.K. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc. Natl. Acad. Sci. USA 102 (2005) 18099-18104
5. Daniels R.A., Turley H., Kimberley F.C., Liu X.S., Mongkolsapaya J., Ch'En P., Xu X.N., Jin B.Q., Pezzella F., and Screaton G.R. Expression of TRAIL and TRAIL receptors in normal and malignant tissues. Cell Res. 15 (2005) 430-438
6. Faddy M.J., Gosden R.G., Gougeon A., Richardson S.J., and Nelson J.F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. 7 (1992) 1342-1346
7. Griffith T.S., and Lynch D.H. TRAIL: a molecule with multiple receptors and control mechanisms. Curr. Opin. Immunol. 10 (1998) 559-563
8. Heikinheimo M., Scandrett J.M., and Wilson D.B. Localization of transcription factor GATA-4 to regions of the mouse embryo involved in cardiac development. Dev. Biol. 164 (1994) 361-373
9. Hymowitz S.G., Christinger H.W., Fuh G., Ultsch M., O'Connell M., Kelley R.F., Ashkenazi A., and de Vos A.M. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol. Cell 4 (1999) 563-571
10. Inoue N., Manabe N., Matsui T., Maeda A., Nakagawa S., Wada S., and Miyamoto H. Roles of tumor necrosis factor-related apoptosis-inducing ligand signaling pathway in granulosa cell apoptosis during atresia in pig ovaries. J. Reprod. Dev. 49 (2003) 313-321
11. Johnson A.L., Ratajczak C., Haugen M.J., Liu H.K., and Woods D.C. Tumor necrosis factor-related apoptosis inducing ligand expression and activity in hen granulosa cells. Reproduction 133 (2007) 609-616
12. LeBlanc H.N., and Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10 (2003) 66-75
13. Li H., Zhu H., Xu C.J., and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the fas pathway of apoptosis. Cell 94 (1998) 491-501
14. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998) 481-490
15. MacFarlane M., Merrison W., Dinsdale D., and Cohen G.M. Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis. J. Cell Biol. 148 (2000) 1239-1254
16. Manabe N., Goto Y., Matsuda-Minehata F., Inoue N., Maeda A., Sakamaki K., and Miyano T. Regulation mechanism of selective atresia in porcine follicles: regulation of granulosa cell apoptosis during atresia. J. Reprod. Dev. 50 (2004) 493-514
17. Marsters S.A., Sheridan J.P., Pitti R.M., Huang A., Skubatch M., Baldwin D., Yuan J., Gurney A., Goddard A.D., Godowski P., et al. A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr. Biol. 7 (1997) 1003-1006
18. Nesterov A., Ivashchenko Y., and Kraft A.S. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene 21 (2002) 1135-1140
19. Nishi Y., Yanase T., Mu Y., Oba K., Ichino I., Saito M., Nomura M., Mukasa C., Okabe T., Goto K., et al. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142 (2001) 437-445
20. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., and Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277 (1997) 815-818
21. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., and Dixit V.M. The receptor for the cytotoxic ligand TRAIL. Science 276 (1997) 111-113
22. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., and Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271 (1996) 12687-12690
23. Qin J.Z., Bacon P., Panella J., Sitailo L.A., Denning M.F., and Nickoloff B.J. Low-dose UV-radiation sensitizes keratinocytes to TRAIL-induced apoptosis. J. Cell. Physiol. 200 (2004) 155-166
24. Sadler T.W. Gametogenesis. Langman's Medical Embryology (1990), Williams & Wilkins, Baltimore, MD, USA 3-20
25. Secchiero P., Gonelli A., Carnevale E., Milani D., Pandolfi A., Zella D., and Zauli G. TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107 (2003) 2250-2256
26. Secchiero P., Melloni E., Heikinheimo M., Mannisto S., Di Pietro R., Iacone A., and Zauli G. TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood 103 (2004) 517-522
27. Song K., Chen Y., Goke R., Wilmen A., Seidel C., Goke A., Hilliard B., and Chen Y. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J. Exp. Med. 191 (2000) 1095-1104
28. Tilly J.L. The molecular basis of ovarian cell death during germ cell attrition, follicular atresia, and luteolysis. Front. Biosci. 1 (1996) d1-d11
29. Vaskivuo T.E., Anttonen M., Herva R., Billig H., Dorland M., te Velde E.R., Stenback F., Heikinheimo M., and Tapanainen J.S. Survival of human ovarian follicles from fetal to adult life: apoptosis, apoptosis-related proteins, and transcription factor GATA-4. J. Clin. Endocrinol. Metab. 86 (2001) 3421-3429
30. Vaskivuo T.E., and Tapanainen J.S. Apoptosis in the human ovary. Reprod. Biomed. Online 6 (2003) 24-35
31. Wada S., Manabe N., Nakayama M., Inou N., Matsui T., and Miyamoto H. TRAIL-decoy receptor 1 plays inhibitory role in apoptosis of granulosa cells from pig ovarian follicles. J. Vet. Med. Sci. 64 (2002) 435-439
32. Walczak H., Degli-Esposti M.A., Johnson R.S., Smolak P.J., Waugh J.Y., Boiani N., Timour M.S., Gerhart M.J., Schooley K.A., Smith C.A., et al. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16 (1997) 5386-5397
33. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., and Smith C.A. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682
34. Woods D.C., Alvarez C., and Johnson A.L. Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells. Gynecol. Oncol. 108 (2008) 632-633-40
35. Woods D.C., Liu H.K., Nishi Y., Yanase T., and Johnson A.L. Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death. Cancer Lett. 260 (2008) 20-27
36. Yan H.H., Mruk D.D., Lee W.M., and Cheng C.Y. Blood-testis barrier dynamics are regulated by testosterone and cytokines via their differential effects on the kinetics of protein endocytosis and recycling in sertoli cells. FASEB J. 22 (2008) 1945-1959
37. Zamai L., Secchiero P., Pierpaoli S., Bassini A., Papa S., Alnemri E.S., Guidotti L., Vitale M., and Zauli G. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood 95 (2000) 3716-3724
38. Zauli G., Pandolfi A., Gonelli A., Di Pietro R., Guarnieri S., Ciabattoni G., Rana R., Vitale M., and Secchiero P. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) Sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. Circ. Res. 92 (2003) 732-740
39. Zauli G., and Secchiero P. The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine Growth Factor Rev. 17 (2006) 245-257